 | • レポートコード：MRC2102QY0677 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の動物血漿・誘導体市場について種類別（免疫グロブリン、フィブリノーゲン、血清アルブミン、ウシ胎児血清、トロンビン、ウシ胎児血清）、用途別（食品＆飲料、医薬品、化粧品、飼料、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・動物血漿・誘導体市場の概要 ・世界の主要地域別動物血漿・誘導体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の動物血漿・誘導体市場規模2015-2026：種類別（免疫グロブリン、フィブリノーゲン、血清アルブミン、ウシ胎児血清、トロンビン、ウシ胎児血清） ・世界の動物血漿・誘導体市場規模2015-2026：用途別（食品＆飲料、医薬品、化粧品、飼料、その他） ・動物血漿・誘導体の米国市場規模2015-2020 ・動物血漿・誘導体のヨーロッパ市場規模2015-2020 ・動物血漿・誘導体の中国市場規模2015-2020 ・動物血漿・誘導体の日本市場規模2015-2020 ・動物血漿・誘導体の東南アジア市場規模2015-2020 ・動物血漿・誘導体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・動物血漿・誘導体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・動物血漿・誘導体の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Animal Blood Plasma and Derivatives Market
The global Animal Blood Plasma and Derivatives market size is projected to reach US$ 1343.1 million by 2026, from US$ 1029.2 million in 2020, at a CAGR of 4.5% during 2021-2026.
Global Animal Blood Plasma and Derivatives Scope and Market Size
The global Animal Blood Plasma and Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Blood Plasma and Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Animal Blood Plasma and Derivatives market is segmented into
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Segment by Application, the Animal Blood Plasma and Derivatives market is segmented into
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
The Animal Blood Plasma and Derivatives market is analysed and market size information is provided by regions (countries). Segment by Application, the Animal Blood Plasma and Derivatives market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Animal Blood Plasma and Derivatives Market Share Analysis
Animal Blood Plasma and Derivatives market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Blood Plasma and Derivatives business, the date to enter into the Animal Blood Plasma and Derivatives market, Animal Blood Plasma and Derivatives product introduction, recent developments, etc.
The major vendors covered:
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
1 Animal Blood Plasma and Derivatives Market Overview
1.1 Animal Blood Plasma and Derivatives Product Scope
1.2 Animal Blood Plasma and Derivatives Segment by Type
1.2.1 Global Animal Blood Plasma and Derivatives Sales by Type (2020-2026)
1.2.2 Immunoglobulin
1.2.3 Fibrinogen
1.2.4 Serum Albumin
1.2.5 Fetal Bovine Serum
1.2.6 Thrombin
1.2.7 New Born Calf Serum
1.3 Animal Blood Plasma and Derivatives Segment by Application
1.3.1 Global Animal Blood Plasma and Derivatives Sales Comparison by Application (2020-2026)
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Feed
1.3.6 Others
1.4 Animal Blood Plasma and Derivatives Market Estimates and Forecasts (2015-2026)
1.4.1 Global Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2026)
1.4.2 Global Animal Blood Plasma and Derivatives Revenue and Growth Rate (2015-2026)
1.4.3 Global Animal Blood Plasma and Derivatives Price Trends (2015-2026)
2 Animal Blood Plasma and Derivatives Estimate and Forecast by Region
2.1 Global Animal Blood Plasma and Derivatives Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Animal Blood Plasma and Derivatives Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)
2.2.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Region (2015-2020)
2.3 Global Animal Blood Plasma and Derivatives Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Animal Blood Plasma and Derivatives Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Animal Blood Plasma and Derivatives Estimates and Projections (2015-2026)
2.4.2 Europe Animal Blood Plasma and Derivatives Estimates and Projections (2015-2026)
2.4.3 China Animal Blood Plasma and Derivatives Estimates and Projections (2015-2026)
2.4.4 Japan Animal Blood Plasma and Derivatives Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Animal Blood Plasma and Derivatives Estimates and Projections (2015-2026)
2.4.6 India Animal Blood Plasma and Derivatives Estimates and Projections (2015-2026)
3 Global Animal Blood Plasma and Derivatives Competition Landscape by Players
3.1 Global Top Animal Blood Plasma and Derivatives Players by Sales (2015-2020)
3.2 Global Top Animal Blood Plasma and Derivatives Players by Revenue (2015-2020)
3.3 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Blood Plasma and Derivatives as of 2019)
3.4 Global Animal Blood Plasma and Derivatives Average Price by Company (2015-2020)
3.5 Manufacturers Animal Blood Plasma and Derivatives Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Animal Blood Plasma and Derivatives Players (Opinion Leaders)
4 Global Animal Blood Plasma and Derivatives Market Size by Type
4.1 Global Animal Blood Plasma and Derivatives Historic Market Review by Type (2015-2020)
4.1.1 Global Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
4.1.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2015-2020)
4.1.3 Global Animal Blood Plasma and Derivatives Price by Type (2015-2020)
4.2 Global Animal Blood Plasma and Derivatives Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Type (2021-2026)
4.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Type (2021-2026)
4.2.3 Global Animal Blood Plasma and Derivatives Price Forecast by Type (2021-2026)
5 Global Animal Blood Plasma and Derivatives Market Size by Application
5.1 Global Animal Blood Plasma and Derivatives Historic Market Review by Application (2015-2020)
5.1.1 Global Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
5.1.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2015-2020)
5.1.3 Global Animal Blood Plasma and Derivatives Price by Application (2015-2020)
5.2 Global Animal Blood Plasma and Derivatives Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Application (2021-2026)
5.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Application (2021-2026)
5.2.3 Global Animal Blood Plasma and Derivatives Price Forecast by Application (2021-2026)
6 United States Animal Blood Plasma and Derivatives Market Facts & Figures
6.1 United States Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
6.2 United States Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
6.3 United States Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
7 Europe Animal Blood Plasma and Derivatives Market Facts & Figures
7.1 Europe Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
7.2 Europe Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
7.3 Europe Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
8 China Animal Blood Plasma and Derivatives Market Facts & Figures
8.1 China Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
8.2 China Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
8.3 China Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
9 Japan Animal Blood Plasma and Derivatives Market Facts & Figures
9.1 Japan Animal Blood Plasma and Derivatives Sales Market Share by Company (3015-3030)
9.2 Japan Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
9.3 Japan Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
10 Southeast Asia Animal Blood Plasma and Derivatives Market Facts & Figures
10.1 Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
11 India Animal Blood Plasma and Derivatives Market Facts & Figures
11.1 India Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
11.2 India Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
11.3 India Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Animal Blood Plasma and Derivatives Business
12.1 Proliant Inc.
12.1.1 Proliant Inc. Corporation Information
12.1.2 Proliant Inc. Business Overview
12.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Products Offered
12.1.5 Proliant Inc. Recent Development
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Thermo Fisher Scientific, Inc. Corporation Information
12.2.2 Thermo Fisher Scientific, Inc. Business Overview
12.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Products Offered
12.2.5 Thermo Fisher Scientific, Inc. Recent Development
12.3 Merck KGaA
12.3.1 Merck KGaA Corporation Information
12.3.2 Merck KGaA Business Overview
12.3.3 Merck KGaA Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck KGaA Animal Blood Plasma and Derivatives Products Offered
12.3.5 Merck KGaA Recent Development
12.4 Kraeber & Co GmbH
12.4.1 Kraeber & Co GmbH Corporation Information
12.4.2 Kraeber & Co GmbH Business Overview
12.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Products Offered
12.4.5 Kraeber & Co GmbH Recent Development
12.5 LAMPIRE Biological Laboratories, Inc.
12.5.1 LAMPIRE Biological Laboratories, Inc. Corporation Information
12.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
12.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Products Offered
12.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
12.6 Lake Immunogenics, Inc.
12.6.1 Lake Immunogenics, Inc. Corporation Information
12.6.2 Lake Immunogenics, Inc. Business Overview
12.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Products Offered
12.6.5 Lake Immunogenics, Inc. Recent Development
12.7 Rocky Mountain Biologicals Inc.
12.7.1 Rocky Mountain Biologicals Inc. Corporation Information
12.7.2 Rocky Mountain Biologicals Inc. Business Overview
12.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Products Offered
12.7.5 Rocky Mountain Biologicals Inc. Recent Development
12.8 ANZCO Foods Ltd.
12.8.1 ANZCO Foods Ltd. Corporation Information
12.8.2 ANZCO Foods Ltd. Business Overview
12.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Products Offered
12.8.5 ANZCO Foods Ltd. Recent Development
12.9 Auckland BioSciences Ltd.
12.9.1 Auckland BioSciences Ltd. Corporation Information
12.9.2 Auckland BioSciences Ltd. Business Overview
12.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Products Offered
12.9.5 Auckland BioSciences Ltd. Recent Development
12.10 Bovogen Biologicals Pty Ltd.
12.10.1 Bovogen Biologicals Pty Ltd. Corporation Information
12.10.2 Bovogen Biologicals Pty Ltd. Business Overview
12.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Products Offered
12.10.5 Bovogen Biologicals Pty Ltd. Recent Development
13 Animal Blood Plasma and Derivatives Manufacturing Cost Analysis
13.1 Animal Blood Plasma and Derivatives Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Animal Blood Plasma and Derivatives
13.4 Animal Blood Plasma and Derivatives Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Animal Blood Plasma and Derivatives Distributors List
14.3 Animal Blood Plasma and Derivatives Customers
15 Market Dynamics
15.1 Animal Blood Plasma and Derivatives Market Trends
15.2 Animal Blood Plasma and Derivatives Opportunities and Drivers
15.3 Animal Blood Plasma and Derivatives Market Challenges
15.4 Animal Blood Plasma and Derivatives Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Animal Blood Plasma and Derivatives Sales (K L) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Animal Blood Plasma and Derivatives Sales (K L) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Animal Blood Plasma and Derivatives Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Animal Blood Plasma and Derivatives Sales (K L) by Region (2015-2020)
Table 5. Global Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)
Table 6. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Animal Blood Plasma and Derivatives Revenue Share by Region (2015-2020)
Table 8. Global Animal Blood Plasma and Derivatives Sales (K L) Forecast by Region (2021-2026)
Table 9. Global Animal Blood Plasma and Derivatives Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Animal Blood Plasma and Derivatives Revenue Share Forecast by Region (2021-2026)
Table 12. Global Animal Blood Plasma and Derivatives (K L) of Key Companies (2015-2020)
Table 13. Global Animal Blood Plasma and Derivatives Sales Share by Company (2015-2020)
Table 14. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Animal Blood Plasma and Derivatives Revenue Share by Company (2015-2020)
Table 16. Global Animal Blood Plasma and Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Blood Plasma and Derivatives as of 2019)
Table 17. Global Animal Blood Plasma and Derivatives Average Price (USD/L) of Key Company (2015-2020)
Table 18. Manufacturers Animal Blood Plasma and Derivatives Manufacturing Sites and Area Served
Table 19. Manufacturers Animal Blood Plasma and Derivatives Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Animal Blood Plasma and Derivatives Players
Table 22. Global Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 23. Global Animal Blood Plasma and Derivatives Sales Share by Type (2015-2020)
Table 24. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Animal Blood Plasma and Derivatives Price (K L) by Type (2015-2020)
Table 26. Global Animal Blood Plasma and Derivatives Sales Share by Type (2021-2026)
Table 27. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Animal Blood Plasma and Derivatives Revenue Share by Type (2021-2026)
Table 29. Global Animal Blood Plasma and Derivatives Price (K L) by Type (2021-2026)
Table 30. Global Animal Blood Plasma and Derivatives Sales (K L) by Application (2015-2020)
Table 31. Global Animal Blood Plasma and Derivatives Sales Share by Application (2015-2020)
Table 32. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Animal Blood Plasma and Derivatives Price (K L) by Application (2015-2020)
Table 34. Global Animal Blood Plasma and Derivatives Sales (K L) by Application (2021-2026)
Table 35. Global Animal Blood Plasma and Derivatives Sales Share by Application (2021-2026)
Table 36. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Animal Blood Plasma and Derivatives Revenue Share by Application (2021-2026)
Table 38. Global Animal Blood Plasma and Derivatives Price (K L) by Application (2021-2026)
Table 39. United States Animal Blood Plasma and Derivatives Sales (K L) by Company (2015-2020)
Table 40. United States Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
Table 41. United States Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 42. United States Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 43. United States Animal Blood Plasma and Derivatives Sales (K L) by Application (2015-2020)
Table 44. United States Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 45. Europe Animal Blood Plasma and Derivatives Sales (K L) by Company (2015-2020)
Table 46. Europe Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
Table 47. Europe Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 48. Europe Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 49. Europe Animal Blood Plasma and Derivatives Sales (K L) by Application (2015-2020)
Table 50. Europe Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 51. China Animal Blood Plasma and Derivatives Sales (K L) by Company (2015-2020)
Table 52. China Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
Table 53. China Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 54. China Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 55. China Animal Blood Plasma and Derivatives Sales (K L) by Application (2015-2020)
Table 56. China Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 57. Japan Animal Blood Plasma and Derivatives Sales (K L) by Company (2015-2020)
Table 58. Japan Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
Table 59. Japan Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 60. Japan Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 61. Japan Animal Blood Plasma and Derivatives Sales (K L) by Application (2015-2020)
Table 62. Japan Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Animal Blood Plasma and Derivatives Sales (K L) by Company (2015-2020)
Table 64. Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 66. Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 68. Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 69. India Animal Blood Plasma and Derivatives Sales (K L) by Company (2015-2020)
Table 70. India Animal Blood Plasma and Derivatives Sales Market Share by Company (2015-2020)
Table 71. India Animal Blood Plasma and Derivatives Sales (K L) by Type (2015-2020)
Table 72. India Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 73. India Animal Blood Plasma and Derivatives Sales (K L) by Application (2015-2020)
Table 74. India Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 75. Proliant Inc. Corporation Information
Table 76. Proliant Inc. Description and Business Overview
Table 77. Proliant Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 78. Proliant Inc. Animal Blood Plasma and Derivatives Product
Table 79. Proliant Inc. Recent Development
Table 80. Thermo Fisher Scientific, Inc. Corporation Information
Table 81. Thermo Fisher Scientific, Inc. Description and Business Overview
Table 82. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 83. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product
Table 84. Thermo Fisher Scientific, Inc. Recent Development
Table 85. Merck KGaA Corporation Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 88. Merck KGaA Animal Blood Plasma and Derivatives Product
Table 89. Merck KGaA Recent Development
Table 90. Kraeber & Co GmbH Corporation Information
Table 91. Kraeber & Co GmbH Description and Business Overview
Table 92. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 93. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product
Table 94. Kraeber & Co GmbH Recent Development
Table 95. LAMPIRE Biological Laboratories, Inc. Corporation Information
Table 96. LAMPIRE Biological Laboratories, Inc. Description and Business Overview
Table 97. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 98. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product
Table 99. LAMPIRE Biological Laboratories, Inc. Recent Development
Table 100. Lake Immunogenics, Inc. Corporation Information
Table 101. Lake Immunogenics, Inc. Description and Business Overview
Table 102. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 103. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product
Table 104. Lake Immunogenics, Inc. Recent Development
Table 105. Rocky Mountain Biologicals Inc. Corporation Information
Table 106. Rocky Mountain Biologicals Inc. Description and Business Overview
Table 107. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 108. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product
Table 109. Rocky Mountain Biologicals Inc. Recent Development
Table 110. ANZCO Foods Ltd. Corporation Information
Table 111. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 112. ANZCO Foods Ltd. Description and Business Overview
Table 113. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product
Table 114. ANZCO Foods Ltd. Recent Development
Table 115. Auckland BioSciences Ltd. Corporation Information
Table 116. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 117. Auckland BioSciences Ltd. Description and Business Overview
Table 118. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product
Table 119. Auckland BioSciences Ltd. Recent Development
Table 120. Bovogen Biologicals Pty Ltd. Corporation Information
Table 121. Bovogen Biologicals Pty Ltd. Description and Business Overview
Table 122. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 123. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product
Table 124. Bovogen Biologicals Pty Ltd. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Animal Blood Plasma and Derivatives Distributors List
Table 128. Animal Blood Plasma and Derivatives Customers List
Table 129. Animal Blood Plasma and Derivatives Market Key Trends
Table 130. Animal Blood Plasma and Derivatives Key Opportunities and Drivers
Table 131. Animal Blood Plasma and Derivatives Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Blood Plasma and Derivatives Product Picture
Figure 2. Global Animal Blood Plasma and Derivatives Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Animal Blood Plasma and Derivatives Market Share by Application in 2020 & 2026
Figure 6. Food & Beverages Examples
Figure 7. Pharmaceuticals Examples
Figure 8. Cosmetics Examples
Figure 9. Feed Examples
Figure 10. Others Examples
Figure 11. Global Animal Blood Plasma and Derivatives Sales (K L) Growth Rate (2015-2026)
Figure 12. Global Animal Blood Plasma and Derivatives Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Animal Blood Plasma and Derivatives Price Trends Growth Rate (2015-2026) (USD/L)
Figure 14. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Animal Blood Plasma and Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Animal Blood Plasma and Derivatives Sales (K L) Growth Rate (2015-2026)
Figure 18. Europe Animal Blood Plasma and Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Animal Blood Plasma and Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Animal Blood Plasma and Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Animal Blood Plasma and Derivatives Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Animal Blood Plasma and Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Animal Blood Plasma and Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Animal Blood Plasma and Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Animal Blood Plasma and Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Animal Blood Plasma and Derivatives Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Animal Blood Plasma and Derivatives Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Animal Blood Plasma and Derivatives Players Market Share by Revenue in Animal Blood Plasma and Derivatives 2015 & 2019
Figure 29. Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Animal Blood Plasma and Derivatives Revenue Share by Type (2015-2020)
Figure 31. Global Animal Blood Plasma and Derivatives Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Animal Blood Plasma and Derivatives Revenue Share by Application (2015-2020)
Figure 33. Global Animal Blood Plasma and Derivatives Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 35. United States Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 36. Europe Animal Blood Plasma and Derivatives Sales Market Share by Company in 2019
Figure 37. Europe Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 38. Europe Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019
Figure 39. China Animal Blood Plasma and Derivatives Sales Market Share by Company in 2019
Figure 40. China Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 41. China Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019
Figure 42. Japan Animal Blood Plasma and Derivatives Sales Market Share by Company in 2019
Figure 43. Japan Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 44. Japan Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019
Figure 45. Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Company in 2019
Figure 46. Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 47. Southeast Asia Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019
Figure 48. India Animal Blood Plasma and Derivatives Sales Market Share by Company in 2019
Figure 49. India Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 50. India Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Animal Blood Plasma and Derivatives
Figure 53. Manufacturing Process Analysis of Animal Blood Plasma and Derivatives
Figure 54. Animal Blood Plasma and Derivatives Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
ウシ血漿誘導体の世界市場レポート2020 Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production. Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen ar…- 血漿分画器の世界市場レポート2020 Market Analysis and Insights: Global Blood Plasma Fractionators Market The global Blood Plasma Fractionators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Blood Plasma Fractionators Scope and Market Size The global Bl…
- 酪酸誘導体の世界市場レポート2020 Butyric acid derivatives are salts and esters of butyric acid also known as botanoic acid. Salts of butyric acid are predominant segment of butyric acid derivatives market. Salts of butyric acid include sodium butyrate, calcium butyrate, potassium butyrate, magnesium butyrate etc. Of these salts, so…
- ウシ胎児血清の世界市場レポート2020 Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum albumin is the major component of FBS. The main sources …
- アルテミシニン誘導体の世界市場レポート2020 Market Analysis and Insights: Global Artemisinin Derivatives Market The global Artemisinin Derivatives market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Artemisinin Derivatives Scope and Market Size The global Artemisinin…